Detalhe da pesquisa
1.
Safety and effectiveness of sarilumab in Japanese patients with rheumatoid arthritis refractory to previous treatments: An interim analysis of a post-marketing surveillance.
Mod Rheumatol
; 34(3): 444-452, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37300807
2.
Haemoglobin changes and disease activity in Japanese patients with rheumatoid arthritis treated with sarilumab.
Clin Exp Rheumatol
; 41(5): 1129-1139, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36305354
3.
The Antimicrobial Peptide Cathelicidin Exerts Immunomodulatory Effects via Scavenger Receptors.
Int J Mol Sci
; 24(1)2023 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36614313
4.
Clinical features of polymyalgia rheumatica patients in Japan: Analysis of real-world data from 2015 to 2020.
Mod Rheumatol
; 34(1): 201-207, 2023 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36881671
5.
Effect of sarilumab on unacceptable pain and inflammation control in Japanese patients with moderately-to-severely active rheumatoid arthritis: Post hoc analysis of a Phase III study (KAKEHASI).
Mod Rheumatol
; 2023 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37606691
6.
Pharmacokinetics, pharmacodynamics, and safety of single-dose subcutaneous sarilumab with or without methotrexate in Japanese patients with rheumatoid arthritis: Two single-dose studies.
Mod Rheumatol
; 33(2): 279-291, 2023 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35445719
7.
[AN ADOLESCENT CASE OF HAE-NL-C1INH (WHO WAS) MISDIAGNOSED WITH WHEAT ALLERGY AND MULTIPLE DRUG ALLERGIES].
Arerugi
; 72(9): 1147-1153, 2023.
Artigo
em Japonês
| MEDLINE | ID: mdl-37967961
8.
Immunogenicity of sarilumab and impact on safety and efficacy in Japanese patients with rheumatoid arthritis: analysis of two Phase 3 randomised clinical trials.
Mod Rheumatol
; 32(4): 686-695, 2022 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34915576
9.
Optimization of the IL-2 Luc assay for immunosuppressive drugs: a novel in vitro immunotoxicity test with high sensitivity and predictivity.
Arch Toxicol
; 95(8): 2755-2768, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34175962
10.
Psoriasis and Antimicrobial Peptides.
Int J Mol Sci
; 21(18)2020 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32947991
11.
Profiling the immunotoxicity of chemicals based on in vitro evaluation by a combination of the Multi-ImmunoTox assay and the IL-8 Luc assay.
Arch Toxicol
; 92(6): 2043-2054, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29594315
12.
Population Pharmacokinetics of Hydroxychloroquine in Japanese Patients With Cutaneous or Systemic Lupus Erythematosus.
Ther Drug Monit
; 38(2): 259-67, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26587870
13.
Severe Anemia from Multiple Gastric Hyperplastic Polyps in a Hemodialysis Patient after Long-term Use of a Proton-pump Inhibitor.
Intern Med
; 63(5): 649-657, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38432892
14.
Glucocorticoid treatment and clinical outcomes in patients with polymyalgia rheumatica: A cohort study using routinely collected health data.
Joint Bone Spine
; 91(3): 105680, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38143016
15.
Serum levels of AGGF1: Potential association with cutaneous and cardiopulmonary involvements in systemic sclerosis.
J Dermatol
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38619119
16.
Increased LL37 in psoriasis and other inflammatory disorders promotes LDL uptake and atherosclerosis.
J Clin Invest
; 134(5)2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194294
17.
LL-37 Might Promote Local Invasion of Melanoma by Activating Melanoma Cells and Tumor-Associated Macrophages.
Cancers (Basel)
; 15(6)2023 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36980564
18.
Clinical guidance of pyoderma gangrenosum 2022.
J Dermatol
; 50(9): e253-e275, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37311717
19.
Discovery and structure-activity relationship of 2,6-disubstituted pyrazines, potent and selective inhibitors of protein kinase CK2.
Bioorg Med Chem Lett
; 22(13): 4358-61, 2012 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22633690
20.
Discovery and structure-activity relationships of urea derivatives as potent and novel CCR3 antagonists.
Bioorg Med Chem Lett
; 22(15): 4951-4, 2012 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22749826